Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R.

J Neurosurg. 2001 Aug;95(2):190-8.

PMID:
11780887
2.

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

Li YM, Suki D, Hess K, Sawaya R.

J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.

PMID:
26495941
3.

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.

Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, Vogelbaum MA.

J Neurosurg. 2014 Nov;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. Epub 2014 Sep 5.

PMID:
25192475
4.

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST.

J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.

PMID:
21548745
5.
6.

Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?

Allahdini F, Amirjamshidi A, Reza-Zarei M, Abdollahi M.

World Neurosurg. 2010 Feb;73(2):128-34; discussion e16. doi: 10.1016/j.wneu.2009.06.001. Epub 2009 Oct 21.

PMID:
20860940
7.

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T; ALA-Glioma Study Group.

Neurosurgery. 2008 Mar;62(3):564-76; discussion 564-76. doi: 10.1227/01.neu.0000317304.31579.17.

PMID:
18425006
8.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
9.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quiñones-Hinojosa AR.

J Neurosurg. 2009 Jan;110(1):156-62. doi: 10.3171/2008.4.17536.

PMID:
18847342
10.

The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.

Chambless LB, Kistka HM, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC.

J Neurooncol. 2015 Jan;121(2):359-64. doi: 10.1007/s11060-014-1640-x. Epub 2014 Oct 26.

PMID:
25344883
11.

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C.

Neuro Oncol. 2011 Dec;13(12):1339-48. doi: 10.1093/neuonc/nor133. Epub 2011 Sep 12. Erratum in: Neuro Oncol. 2014 Oct;16(10):1429.

12.

Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article.

Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2011 Mar;114(3):587-94. doi: 10.3171/2010.8.JNS1081. Epub 2010 Oct 1.

13.

The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.

Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada K, Kuratsu J, Ishimaru Y, Ushio Y.

J Neurosurg. 2004 Aug;101(2):219-26. Review.

PMID:
15309911
14.

Glioblastoma surgery with and without intraoperative MRI at 3.0T.

Napolitano M, Vaz G, Lawson TM, Docquier MA, van Maanen A, Duprez T, Raftopoulos C.

Neurochirurgie. 2014 Aug;60(4):143-50. doi: 10.1016/j.neuchi.2014.03.010. Epub 2014 Jun 26.

15.

A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A.

J Neurosurg. 2010 May;112(5):997-1004. doi: 10.3171/2009.9.JNS09805.

PMID:
19817542
16.

The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.

Gulati S, Jakola AS, Nerland US, Weber C, Solheim O.

World Neurosurg. 2011 Dec;76(6):572-9. doi: 10.1016/j.wneu.2011.06.014.

PMID:
22251506
17.

Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?

Nakamura H, Murakami R, Hirai T, Kitajima M, Yamashita Y.

Acta Radiol. 2013 Mar 1;54(2):214-20. doi: 10.1258/ar.2012.120525. Epub 2012 Nov 8.

PMID:
23138021
18.

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.

Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL.

Neurosurgery. 1997 Nov;41(5):1028-36; discussion 1036-8.

PMID:
9361056
19.
20.

Multiple resections for patients with glioblastoma: prolonging survival.

Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2013 Apr;118(4):812-20. doi: 10.3171/2012.9.JNS1277. Epub 2012 Oct 19.

Supplemental Content

Support Center